Best Practice & Research Clinical Haematology
Volume 19, Issue 4 , Pages 795-810, December 2006

Alemtuzumab in T-cell lymphoproliferative disorders

  • Claire E. Dearden, BSc, MD, FRCP, FRCPath (Consultant Haematologist)

      Affiliations

    • Corresponding Author InformationCorresponding author. Tel.: +44 20 8661 3655; Fax: +44 20 8642 9634.
    • ,
  • Estella Matutes, MD, PhD, FRCPath (Consultant Haematologist)

Royal Marsden NHS Foundation Trust, Downs Road, Sutton, Surrey SM2 5PT, UK

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

PII: S1521-6926(06)00037-5

doi:10.1016/j.beha.2006.05.005

Best Practice & Research Clinical Haematology
Volume 19, Issue 4 , Pages 795-810, December 2006

Article Tools

* Image Usage & Resolution